NANOVIRICIDES, INC.
NANOVIRICIDES, INC. (NNVC): 7 pipeline candidates · ~5 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
5.1 months
D/E 0.12 · 0% dilution
Lead: Phase 2
7 candidates
N/A
N/A
A transparent, data-derived signal for NANOVIRICIDES, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$30.6M
Cash
$3.2M
Quarterly Burn
$1.9M
Runway
5.1 mo
Revenue
$0
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
| Drug | Phase |
|---|---|
| nv-387 | Phase 2 |
| nv-387-ribvp | Preclinical |
| nv-387-rp | Preclinical |
| nv-cov-2 | Preclinical |
| nv-cov-2-r | Preclinical |
| nv-hhv-1 | Preclinical |
| nv-hiv-1 | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
46
Total value held
$1.9M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 1,022,954 | $933K |
| geode capital management, llc | 225,381 | $206K |
| blackrock, inc. | 158,752 | $145K |
| renaissance technologies llc | 134,900 | $123K |
| susquehanna international group, llp | 99,031 | $90K |
| vanguard fiduciary trust co | 90,060 | $82K |
| state street corp | 54,206 | $49K |
| bridgeway capital management, llc | 36,039 | $33K |
| citadel advisors llc | 35,900 | $33K |
| xtx topco ltd | 35,432 | $32K |
Showing top 10 of 46 institutional holders of NANOVIRICIDES, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in NANOVIRICIDES, INC.'s pipeline?
NANOVIRICIDES, INC. (NNVC) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is NANOVIRICIDES, INC.'s lead drug candidate?
NANOVIRICIDES, INC.'s most advanced tracked candidate is nv-387 (Phase 2) for COVID infection, RSV infection, Influenza, Smallpox, MPox.
What is NANOVIRICIDES, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, NANOVIRICIDES, INC. has approximately 5.1 months of cash runway.
What is NANOVIRICIDES, INC.'s market capitalization?
NANOVIRICIDES, INC.'s market capitalization is approximately $30.6M.
Who is the CEO of NANOVIRICIDES, INC.?
Dr. Anil R. Diwan Ph.D. is the chief executive officer of NANOVIRICIDES, INC. (NNVC).
Get the full picture on NANOVIRICIDES, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.